secwatch / observer
8-K filed May 8, 2024, 7:59 PM ET ticker MKSI CIK 0001049502
earnings confidence high sentiment positive materiality 0.80

MKS Instruments Q1 revenue $868M, non-GAAP EPS $1.18 beat guidance

MKS INC

2024-Q1 EPS reported $0.22 revenue$868,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MKS INC reported the second quarter of 2024 results: revenue $860 million, plus or minus $40 million, EPS $0.93, plus or minus $0.26. Guidance initiated.

Period
the second quarter of 2024
Revenue
$860 million, plus or minus $40 million
EPS
$0.93, plus or minus $0.26
Guidance
initiated
Result
guidance update
Exact text from the filing
Second Quarter 2024 Outlook For the second quarter of 2024, the Company expects revenue of $860 million, plus or minus $40 million, Adjusted EBITDA of $197 million, plus or minus $23 million, and Non-GAAP net earnings per diluted share of $0.93, plus or minus $0.26.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MKS INC reported the quarter ended March 31, 2024 results: revenue $868 million, net income $15 million, EPS $0.22.

Period
the quarter ended March 31, 2024
Revenue
$868 million
Net income
$15 million
EPS
$0.22
Result
reported results
Exact text from the filing
MKS Instruments Reports First Quarter 2024 Financial Results • Quarterly revenue of $868 million, above the midpoint of guidance • Quarterly GAAP net income of $15 million and net income per share of $0.22 • Quarterly Adjusted EBITDA of $217 million and Non-GAAP net earnings per diluted share of $1.18, exceeding the high-end of guidance
View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

MKS INC filing history →

Source: SEC EDGAR
accession 0000950170-24-055783
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.